Clinical Trial Update: Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating continuation of metformin to improve perioperative glycemic control; the study is withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: McMaster University | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: WITHDRAWN